Compare SIGA & EQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
EQV Ventures Acquisition Corp is a blank check company.